Comments
Armed antibody delays spread of certain breast cancers
03.06.2012. | CHICAGO (Reuters) - A study of Roche's experimental "armed antibody" found it extended the length of time breast cancer patients lived without their disease getting worse, marking the second successful pivotal trial in this new class of cancer drugs....
